Bank of America’s Abiomed Inc ABMD Stock Holding History

Bank of America’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-209,427	Closed	-$51.4M	–	8603
2022 Q3	$51.4M	Sell	209,427 -24,425	-10%	-$6.6M	0.01%	1249
2022 Q2	$57.9M	Buy	233,852 +29,258	+14%	+$7.9M	0.01%	1175
2022 Q1	$67.8M	Buy	204,594 +1,664	+0.8%	+$512K	0.01%	1160
2021 Q4	$72.9M	Sell	202,930 -29,467	-13%	-$9.96M	0.01%	1170
2021 Q3	$75.6M	Buy	232,397 +25,495	+12%	+$8.64M	0.01%	1101
2021 Q2	$64.6M	Sell	206,902 -23,137	-10%	-$7.1M	0.01%	1200
2021 Q1	$73.3M	Buy	230,039 +17,425	+8%	+$5.58M	0.01%	1038
2020 Q4	$68.9M	Sell	212,614 -3,618	-2%	-$1M	0.01%	981
2020 Q3	$59.9M	Buy	216,232 +61,344	+40%	+$17.7M	0.01%	983
2020 Q2	$37.4M	Sell	154,888 -16,884	-10%	-$3.39M	0.01%	1182
2020 Q1	$24.9M	Buy	171,772 +65,741	+62%	+$10.9M	﹤0.01%	1358
2019 Q4	$18.1M	Sell	106,031 -77,875	-42%	-$14.4M	﹤0.01%	1974
2019 Q3	$32.7M	Sell	183,906 -43,279	-19%	-$9.36M	﹤0.01%	1423
2019 Q2	$59.2M	Buy	227,185 +81,165	+56%	+$21.5M	0.01%	1015
2019 Q1	$41.7M	Sell	146,020 -4,007	-3%	-$1.33M	0.01%	1243
2018 Q4	$48.8M	Buy	150,027 +7,959	+6%	+$2.76M	0.01%	1012
2018 Q3	$63.9M	Buy	142,068 +11,151	+9%	+$4.4M	0.01%	952
2018 Q2	$53.6M	Sell	130,917 -64,560	-33%	-$23.4M	0.01%	1043
2018 Q1	$56.9M	Buy	195,477 +169,643	+657%	+$43M	0.01%	972
2017 Q4	$4.84M	Buy	25,834 +1,752	+7%	+$327K	﹤0.01%	3152
2017 Q3	$4.06M	Buy	24,082 +5,106	+27%	+$772K	﹤0.01%	3364
2017 Q2	$2.72M	Buy	18,976 +1,380	+8%	+$185K	﹤0.01%	3617
2017 Q1	$2.2M	Sell	17,596 -18,217	-51%	-$2.11M	﹤0.01%	3784
2016 Q4	$4.04M	Sell	35,813 -36,408	-50%	-$4.22M	﹤0.01%	3136
2016 Q3	$9.29M	Sell	72,221 -64,701	-47%	-$7.75M	﹤0.01%	2297
2016 Q2	$15M	Sell	136,922 -35,998	-21%	-$3.58M	﹤0.01%	1819
2016 Q1	$16.4M	Buy	172,920 +21,923	+15%	+$1.85M	﹤0.01%	1712
2015 Q4	$13.6M	Buy	150,997 +36,036	+31%	+$3.06M	﹤0.01%	1974
2015 Q3	$10.7M	Buy	114,961 +47,074	+69%	+$4.15M	﹤0.01%	2166
2015 Q2	$4.46M	Buy	67,887 +40,393	+147%	+$2.68M	﹤0.01%	2696
2015 Q1	$1.97M	Sell	27,494 -17,178	-38%	-$932K	﹤0.01%	3259
2014 Q4	$1.7M	Buy	44,672 +12,619	+39%	+$398K	﹤0.01%	3542
2014 Q3	$796K	Buy	32,053 +9,206	+40%	+$233K	﹤0.01%	4176
2014 Q2	$574K	Sell	22,847 -31,952	-58%	-$744K	﹤0.01%	4483
2014 Q1	$1.43M	Sell	54,799 -10,829	-17%	-$300K	﹤0.01%	3540
2013 Q4	$1.75M	Buy	65,628 +17,362	+36%	+$429K	﹤0.01%	3447
2013 Q3	$920K	Sell	48,266 -11,460	-19%	-$262K	﹤0.01%	4019
2013 Q2	$1.29M	Buy	+59,726	New	+$1.2M	﹤0.01%	3726

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's ABMD Position: Q4 2022 in Review

Bank of America sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 209,427 shares — an estimated $51.4M sold.

Bank of America first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $75.6M in Q3 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Bank of America reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Bank of America sold 209,427 Abiomed Inc shares in Q4 2022, an estimated $51.4M.
Bank of America first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Bank of America's Abiomed Inc position peaked at $75.6M in Q3 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.